Juvenile methylphenidate exposure and factors that influence incentive processing

Developmental Neuroscience

Volumn 31, Issue 1-2, 2009, Pages 95-106

  Brenhouse, Heather C ^a   Napierata, Lee ^a   Kussmaul, Lucinda ^a   Leussis, Melanie ^a   Andersen, Susan L ^a  

^a MCLEAN HOSPITAL   (United States)

Author keywords

Imprinting; Methylphenidate; Place conditioning; Stimulant

Indexed keywords

COCAINE; METHYLPHENIDATE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EXPOSURE; DRUG METABOLISM; ENANTIOMER; FEMALE; GROUPS BY AGE; LOW DRUG DOSE; MALE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; SEX DIFFERENCE;

ADMINISTRATION, ORAL; AGING; ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; CONDITIONING, OPERANT; FEMALE; INJECTIONS, INTRAPERITONEAL; MALE; METHYLPHENIDATE; MOTIVATION; MOTOR ACTIVITY; RATS; RATS, SPRAGUE-DAWLEY; SEX CHARACTERISTICS; STEREOISOMERISM; SUBSTANCE-RELATED DISORDERS;

EID: 65349122495     PISSN: 03785866     EISSN: None     Source Type: Journal    
DOI: 10.1159/000207498     Document Type: Article

References (73)

1. Wagner FA, Anthony JC: From first drug use to drug dependence; developmental periods of risk for dependence upon marijuana, cocaine, and alcohol. Neuropsychopharmacology 2002; 26: 479-488.
2. Johnston LD, et al: Monitoring the future. National results on adolescent drug use. Overview of key findings. 2007.
3. Rapoport JL, Buchsbaum MS, Zahn TP, Weingartner H, Ludlow C, Mikkelsen EJ: Dextroamphetamine: cognitive and behavioral effects in normal prepubertal boys. Science 1978; 199: 560-563.
4. Wilens TE, Faraone SV, Biederman J, Gunawardene S: Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics 2003; 111: 179-185.
5. Dafny N, Yang PB: The role of age, genotype, sex, and route of acute and chronic administration of methylphenidate: a review of its locomotor effects. Brain Res Bull 2006; 68: 393-405.
6. Achat-Mendes C, Anderson KL, Itzhak Y: Methylphenidate and MDMA adolescent exposure in mice: long-lasting consequences on cocaine-induced reward and psychomotor stimulation in adulthood. Neuropharmacology 2003; 45: 106-115.
7. Andersen SL, Arvanitogiannis A, Pliakas AM, LeBlanc C, Carlezon WA Jr: Altered responsiveness to cocaine in rats exposed to methylphenidate during development. Nat Neurosci 2002; 5: 13-14.
8. Carlezon WA Jr, Mague SD, Andersen SL: Enduring behavioral effects of early exposure to methylphenidate in rats. Biol Psychiatry 2003; 54: 1330-1337.
9. Brandon CL, Marinelli M, Baker LK, White FJ: Enhanced reactivity and vulnerability to cocaine following methylphenidate treatment in adolescent rats. Neuropsychopharmacology 2001; 25: 651-661.
10. Schenk S, Izenwasser S: Pretreatment with methylphenidate sensitizes rats to the reinforcing effects of cocaine. Pharmacol Biochem Behav 2002; 72: 651-657.
11. McFadyen MP, Brown RE, Carrey N: Subchronic methylphenidate administration has no effect on locomotion, emotional behavior, or water maze learning in prepubertal mice. Dev Psychobiol 2002; 41: 123-132.
12. Volkow ND: What do we know about drug addiction? Am J Psychiatry 2005; 162: 1401-1402.
13. Everitt BJ, Robbins TW: Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci 2005; 8: 1481-1489.
14. Berridge KC: The debate over dopamine's role in reward: the case for incentive salience. Psychopharmacology (Berl) 2007; 191: 391-431.
15. Roberts DC, Morgan D, Liu Y: How to make a rat addicted to cocaine. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31: 1614-1624.
16. Tzschentke TM: Measuring reward with the conditioned place preference (CPP) paradigm: uPate of the last decade. Addict Biol 2007; 12: 227-462.
17. Kuczenski R, Segal DS: Exposure of adolescent rats to oral methylphenidate: preferential effects on extracellular norepinephrine and absence of sensitization and cross-sensitization to methamphetamine. J Neurosci 2002; 22: 7264-7271.
18. Crawford CA, McDougall SA, Meier TL, Collins RL, Watson JB: Repeated methylphenidate treatment induces behavioral sensitization and decreases protein kinase A and dopamine-stimulated adenylyl cyclase activity in the dorsal striatum. Psychopharmacology (Berl) 1998; 136: 34-43.
19. Torres-Reveron A, Dow-Edwards DL: Repeated administration of methylphenidate in young, adolescent, and mature rats affects the response to cocaine later in adulthood. Psychopharmacology (Berl) 2005; 181: 38-47.
20. McDougall SA, Collins RL, Karper PE, Watson JB, Crawford CA: Effects of repeated methylphenidate treatment in the young rat: sensitization of both locomotor activity and stereotyped sniffing. Exp Clin Psychopharmacol 1999; 7: 208-218.
21. McDougall SA, Duke MA, Bolanos CA, Crawford CA: Ontogeny of behavioral sensitization in the rat: effects of direct and indirect dopamine agonists. Psychopharmacology (Berl) 1994;116: 483-490.
22. Brenhouse HC, Stellar JR: c-Fos and delta-FosB expression are differentially altered in distinct subregions of the nucleus accumbens shell in cocaine-sensitized rats. Neuroscience 2006; 137: 773-780.
23. Carr GD, Phillips AG, Fibiger HC: Independence of amphetamine reward from locomotor stimulation demonstrated by conditioned place preference. Psychopharmacology 1988; 94: 221-226.
24. Everitt BJ, Morris KA, O'Brien A, Robbins TW: The basolateral amygdala-ventral striatal system and conditioned place preference: further evidence of limbic-striatal interactions underlying reward-related processes. Neuroscience 1991; 42: 1-18.
25. Tzschentke TM: Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog Neurobiol 1998; 56: 613-672.
26. Carlezon WA Jr: Place conditioning to study drug reward and aversion. Methods Mol Med 2003; 84: 243-249.
27. Izenwasser S, Coy AE, Ladenheim B, Loeloff RJ, Cadet JL, French D: Chronic methylphenidate alters locomotor activity and dopamine transporters differently from cocaine. Eur J Pharmacol 1999; 373: 187-193.
28. Augustyniak PN, Kourrich S, Rezazadeh SM, Stewart J, Arvanitogiannis A: Differential behavioral and neurochemical effects of cocaine after early exposure to methylphenidate in an animal model of attention deficit hyperactivity disorder. Behav Brain Res 2006; 167: 379-382.
29. Brenhouse H, Sonntag KC, Andersen SL: Transient D 1 dopamine receptor over-expression on prefrontal cortex projection neurons: a mechanism for enhanced motivational salience of drug cues in adolescence. J Neurosci 2008; 28: 2375-2382.
30. Melnick SM, Dow-Edwards DL: Differential behavioral responses to chronic amphetamine in adult male and female rats exposed to postnatal cocaine treatment. Pharmacol Biochem Behav 2001; 69: 219-224.
31. Becker JB, Hu M: Sex differences in drug abuse. Front Neuroendocrinol 2008; 29: 36-47.
32. Balster RL, Schuster CR: Fixed-interval schedule of cocaine reinforcement: effect of dose and infusion duration. J Exp Anal Behav 1973; 20: 119-129.
33. Berridge CW, Devilbiss DM, Andrzejewski ME, Arnsten AF, Kelley AE, Schmeichel B, Hamilton C, Spencer RC: Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function. Biol Psychiatry 2006; 60: 1111-1120.
34. Davids E, Zhang K, Tarazi FI, Baldessarini RJ: Stereoselective effects of methylphenidate on motor hyperactivity in juvenile rats induced by neonatal 6-hydroxydopamine lesioning. Psychopharmacology (Berl) 2002; 160: 92-98.
35. Patrick KS, González MA, Straughn AB, Markowitz JS: New methylphenidate formulations for the treatment of attention-deficit/ hyperactivity disorder. Expert Opin Drug Deliv 2005; 2: 121-143.
36. Walker QD, Nelson CJ, Smith D, Kuhn CM: Vaginal lavage attenuates cocaine-stimulated activity and establishes place preference in rats. Pharmacol Biochem Behav 2002; 73: 743-752.
37. Wargin W, Patrick K, Kilts C, Gualtieri CT, Ellington K, Mueller RA, Kraemer G, Breese GR: Pharmacokinetics of methylphenidate in man, rat and monkey. J Pharmacol Exp Ther 1983; 226: 382-386.
38. Carlezon WA Jr, Thome J, Olson VG, Lane-Ladd SB, Brodkin ES, Hiroi N, Duman RS, Neve RL, Nestler EJ: Regulation of cocaine reward by CREB. Science 1998; 282: 2272-2275.
39. Mueller D, Stewart J: Cocaine-induced conditioned place preference: reinstatement by priming injections of cocaine after extinction. Behav Brain Res 2000; 115: 39-47.
40. McClung CA, Nestler EJ: Neuroplasticity mediated by altered gene expression. Neuropsychopharmacology 2008; 33: 3-17.
41. Kosofsky BE, Genova LM, Hyman SE: Postnatal age defines specificity of immediate early gene induction by cocaine in developing rat brain. J Comp Neurol 1995; 351: 27-40.
42. Kosofsky BE, Hyman SE: No time for complacency: the fetal brain on drugs. J Comp Neurol 2001; 435: 259-262.
43. Hyman SE: Methylphenidate-induced plasticity: what should we be looking for? Biol Psychiatry 2003; 54: 1310-1311.
44. Badanich KA, Adler KJ, Kirstein CL: Adolescents differ from adults in cocaine conditioned place preference and cocaine-induced dopamine in the nucleus accumbens septi. Eur J Pharmacol 2006; 550: 95-106.
45. Jezierski G, Zehle S, Bock J, Braun K, Gruss M: Early stress and chronic methylphenidate cross-sensitize dopaminergic responses in the adolescent medial prefrontal cortex and nucleus accumbens. J Neurochem 2007;103: 2234-2244.
46. Andersen SL, Napierata L, Brenhouse HC, Sonntag KC: Juvenile methylphenidate modulates reward-related behaviors and cerebral blood flow by decreasing cortical D 3 receptors. Eur J Neurosci 2008; 27: 2962-2972.
47. Kalivas PW, Duffy P: Time course of extracellular dopamine and behavioral sensitization to cocaine. I. Dopamine axon terminals. J Neurosci 1993; 13: 266-275.
48. Yano M, Steiner H: Methylphenidate and cocaine: the same effects on gene regulation? Trends Pharmacol Sci 2007; 28: 588-596.
49. Caster JM, Walker QD, Kuhn CM: Enhanced behavioral response to repeated-dose cocaine in adolescent rats. Psychopharmacology (Berl) 2005; 183: 218-225.
50. Guerriero RM, Hayes MM, Dhaliwal SK, Ren JQ, Kosofsky BE: Preadolescent methylphenidate versus cocaine treatment differ in the expression of cocaine-induced locomotor sensitization during adolescence and adulthood. Biol Psychiatry 2006; 60: 1171-1180.
51. Chase T, Carrey N, Soo E, Wilkinson M: Methylphenidate regulates activity regulated cytoskeletal associated but not brain-derived neurotrophic factor gene expression in the developing rat striatum. Neuroscience 2007; 144: 969-984.
52. Bolanos CA, Barrot M, Berton O, Wallace-Black D, Nestler EJ: Methylphenidate treatment during pre-and periadolescence alters behavioral responses to emotional stimuli at adulthood. Biol Psychiatry 2003; 54: 1317-1329.
53. Gerasimov MR, Franceschi M, Volkow ND, Gifford A, Gatley SJ, Marsteller D, Molina PE, Dewey SL: Comparison between intraperitoneal and oral methylphenidate administration: a microdialysis and locomotor activity study. J Pharmacol Exp Ther 2000; 295: 51-57.
54. Volkow ND, Wang GJ, Fowler JS, Fischman M, Foltin R, Abumrad NN, Gatley SJ, Logan J, Wong C, Gifford A, Ding YS, Hitzemann R, Pappas N: Methylphenidate and cocaine have a similar in vivo potency to block dopamine transporters in the human brain. Life Sci 1999; 65:PL7-PL12.
55. Dow-Edwards DL, Busidan Y: Behavioral responses to dopamine agonists in adult rats exposed to cocaine during the preweaning period. Pharmacol Biochem Behav 2001; 70: 23-30.
56. Mague SD, Andersen SL, Carlezon WA Jr: Early developmental exposure to methylphenidate reduces cocaine-induced potentiation of brain stimulation reward in rats. Biol Psychiatry 2005; 57: 120-125.
57. Teicher MH, Polcari A, Foley M, Valente E, McGreenery CE, Chang WW, McKay G, Midha KK: Methylphenidate blood levels and therapeutic response in children with attention-deficit hyperactivity disorder: I. Effects of different dosing regimens. J Child Adolesc Psychopharmacol 2006; 16: 416-431.
58. Dow-Edwards D, Fico TA, Osman M, Gamagaris Z, Hutchings DE: Comparison of oral and subcutaneous routes of cocaine administration on behavior, plasma drug concentration and toxicity in female rats. Pharmacol Biochem Behav 1989; 33: 167-173.
59. Li Y, Robinson TE, Bhatnagar S: Effects of maternal separation on behavioural sensitization produced by repeated cocaine administration in adulthood. Brain Res 2003; 960: 42-47.
60. Aoyama T, Kotaki H, Sawada Y, Iga T: Pharmacokinetics and pharmacodynamics of methylphenidate enantiomers in rats. Psychopharmacology (Berl) 1996; 127: 117-122.
61. Srinivas NR, Hubbard JW, Quinn D, Midha KK: Enantioselective pharmacokinetics and pharmacodynamics of dl-threo-methylphenidate in children with attention deficit hyperactivity disorder. Clin Pharmacol Ther 1992; 52: 561-568.
62. Biederman J, Wilens T, Mick E, Spencer T, Faraone SV: Pharmacotherapy of attentiondeficit/ hyperactivity disorder reduces risk for substance use disorder. Pediatrics 1999; 104:e20.
63. Hechtman L, Weiss G, Perlman T: Hyperactives as young adults: past and current substance abuse and antisocial behavior. Am J Orthopsychiatry 1984; 54: 415-425.
64. Loney J, Kramer J, Salisbury H: Medicated versus unmedicated ADHD children-adult involvement with legal and illegal drugs; in Jensen PS, Cooper JR (eds): Attention Deficit Hyperactivity Disorder -State of the Science, Best Practices. Kingston, Civic Research Institute, 2002, pp 1-16.
65. Gaytan O, Yang P, Swann A, Dafny N: Diurnal differences in sensitization to methylphenidate. Brain Res 2000; 864: 24-39.
66. Hu M, Becker JB: Effects of sex and estrogen on behavioral sensitization to cocaine in rats. J Neurosci 2003; 23: 693-699.
67. Glick SD, Hinds PA, Shapiro RM: Cocaineinduced rotation: sex-dependent differences between left-and right-sided rats. Science 1983; 221: 775-777.
68. Lynch WJ, Carroll ME: Sex differences in the acquisition of intravenously self-administered cocaine and heroin in rats. Psychopharmacology (Berl) 1999; 144: 77-82.
69. Russo SJ, Festa ED, Fabian SJ, Gazi FM, Kraish M, Jenab S, Quiñones-Jenab V: Gonadal hormones differentially modulate cocaine-induced conditioned place preference in male and female rats. Neuroscience 2003; 120: 523-533.
70. Andersen SL, Rutstein M, Benzo JM, Hostetter JC, Teicher MH: Sex differences in dopamine receptor overproduction and elimination. Neuroreport 1997; 8: 1495-1498.
71. Nazarian A, Russo SJ, Festa ED, Kraish M, Quinones-Jenab V: The role of D 1 and D 2 receptors in the cocaine conditioned place preference of male and female rats. Brain Res Bull 2004; 63: 295-299.
72. Bazzett TJ, Becker JB: Sex differences in the rapid and acute effects of estrogen on striatal D 2 dopamine receptor binding. Brain Res 1994; 637: 163-172.
73. Andersen SL: Stimulants and the developing brain. TINS 2005; 26: 237-243.